Researchers have finally cracked the code on how plants create a rare natural compound that shows promise in fighting cancer. This breakthrough could lead to new, more affordable ways to produce this powerful substance for medical use.

Scientists at the University of British Columbia Okanagan have uncovered the precise biological steps plants use to make mitraphylline. This rare compound has attracted significant attention in the medical community for its potential to fight cancer and reduce inflammation in the body.

What Is Mitraphylline and Why Does It Matter?

Mitraphylline belongs to a special group of plant chemicals called spirooxindole alkaloids. These molecules are known for their unusual twisted ring structures, which give them powerful biological effects. Scientists have studied these compounds for years because of their ability to fight tumors and calm inflammation.

However, until now, no one knew exactly how plants managed to build these complex molecules. This missing knowledge has prevented researchers from being able to produce the compound in large enough amounts for thorough testing and potential medical use.

For readers, this research matters because many promising cancer-fighting drugs come from natural sources. When scientists understand how nature creates these compounds, they can find ways to make them in laboratories without harming rare plants or relying on expensive extraction methods.

The Discovery: Finding Nature’s Assembly Line

The mystery began to unravel in 2023 when Dr. Thu-Thuy Dang’s team at UBC Okanagan’s Irving K. Barber Faculty of Science identified the first known plant enzyme capable of twisting a molecule into the distinctive spiro shape. This was a critical first step, but the full picture remained incomplete.

Building on that earlier finding, doctoral student Tuan-Anh Nguyen led new research that uncovered two critical enzymes involved in producing mitraphylline. One enzyme organizes the molecule into the correct three-dimensional structure. The second enzyme transforms it into mitraphylline itself.

“This is similar to finding the missing links in an assembly line,” says Dr. Dang, UBC Okanagan Principal’s Research Chair in Natural Products Biotechnology. “It answers a long-standing question about how nature builds these complex molecules and gives us a new way to replicate that process.”

Where Does Mitraphylline Come From Naturally?

Mitraphylline is extremely rare in nature. It exists only in tiny amounts inside tropical trees such as Mitragyna, commonly known as kratom, and Uncaria, known as cat’s claw. Both plants belong to the coffee family.

This scarcity creates a major problem for medical research. Many promising natural compounds are found only in trace quantities inside plants, making them difficult and expensive to recreate in laboratories. Mitraphylline is one of those rare substances.

Experts in natural products chemistry have long noted that extracting enough of these compounds from plants for clinical trials would require harvesting massive amounts of plant material, which is neither practical nor environmentally sustainable.

What Experts Say About This Breakthrough

Medical researchers and natural product scientists have been searching for ways to produce these compounds more efficiently for decades. The discovery of these specific enzymes represents a major step forward in the field of natural products biotechnology.

Dr. Dang explains that plants are essentially “fantastic natural chemists.” They have evolved over millions of years to create complex molecules that serve various purposes, from defending against pests to attracting pollinators. Now, scientists can learn from these natural chemical factories.

“With this discovery, we have a green chemistry approach to accessing compounds with enormous pharmaceutical value,” says Nguyen. “This is a result of UBC Okanagan’s research environment, where students and faculty work closely to solve problems with global reach.”

Nguyen also reflected on the experience of contributing to the breakthrough. “Being part of the team that uncovered the enzymes behind spirooxindole compounds has been amazing,” Nguyen adds. “UBC Okanagan’s mentorship and support made this possible, and I’m excited to keep growing as a researcher here in Canada.”

How This Affects Future Cancer Research

Now that researchers have identified the enzymes responsible for shaping and assembling mitraphylline, they have a clearer path toward producing the compound and related molecules in more sustainable ways. This means scientists could potentially grow these compounds in yeast or bacteria, similar to how insulin is now produced using genetically modified microbes.

This approach offers several advantages:

• It eliminates the need to harvest rare tropical plants
• It reduces production costs significantly
• It allows for larger quantities to be made for research
• It creates a more environmentally friendly manufacturing process

The project brought together Dr. Dang’s laboratory at UBC Okanagan and Dr. Satya Nadakuduti’s research group at the University of Florida. This international collaboration highlights how modern science often requires teams working across borders to solve complex problems.

What Comes Next for This Research

Dr. Dang’s team is already planning their next steps. “Our next steps will focus on adapting their molecular tools to create a wider range of therapeutic compounds,” she says. This means the discovery could lead to new treatments not just for cancer, but potentially for other conditions involving inflammation.

Funding for the work came from Canada’s Natural Sciences and Engineering Research Council’s Alliance International Collaboration program, the Canada Foundation for Innovation, and the Michael Smith Health Research BC Scholar Program. Additional support was provided by the United States Department of Agriculture’s National Institute of Food and Agriculture.

Practical Takeaways for Readers

While this research is still in its early stages, it represents an important step toward developing new cancer treatments from natural sources. Here is what readers should understand:

• This is basic scientific research, not a treatment ready for patients
• The discovery helps scientists understand how to produce these compounds more efficiently
• Clinical trials for any potential drugs would still be years away
• Natural compounds like mitraphylline are not the same as herbal supplements sold in stores
• Always talk to a doctor before using any plant-based products for medical purposes

For those interested in how natural products become medicines, this research demonstrates the long and careful process required. From identifying a promising compound in a plant to understanding how it is made, each step builds the foundation for future medical breakthroughs.

Materials provided by University of British Columbia Okanagan. Note: Content may be edited for style and length.

Source: ScienceDaily